{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T20:14:38Z","timestamp":1649103278303},"reference-count":0,"publisher":"American Society for Microbiology","issue":"8","license":[{"start":{"date-parts":[[1992,8,1]],"date-time":"1992-08-01T00:00:00Z","timestamp":712627200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["J Clin Microbiol"],"published-print":{"date-parts":[[1992,8]]},"abstract":"<jats:p>To support future clinical studies, in vitro susceptibility tests were examined to determine whether Neisseria gonorrhoeae could be tested reliably against two beta-lactam-clavulanate combinations. All isolates that were tested appeared to be susceptible to amoxicillin and ticarcillin in combination with clavulanic acid. In the absence of resistant isolates, only a breakpoint for a susceptible category could be defined for agar dilution tests with amoxicillin-clavulanic acid (MIC of less than or equal to 2.0\/1.0 micrograms\/ml is tentatively proposed). For disk diffusion tests, a corresponding breakpoint zone diameter of greater than or equal to 28 mm is suggested. The validity of the breakpoints for penicillinase-negative penicillin-resistant strains awaits clinical data. Proposed quality control limits for testing amoxicillin-clavulanic acid by agar dilution and disk diffusion methods are a MIC of 0.25\/0.125 to 1.0\/0.5 micrograms\/ml and zones of 30 to 40 mm in diameter for N. gonorrhoeae ATCC 49226, a MIC of 0.125\/0.06 to 0.5\/0.25 micrograms\/ml for Staphylococcus aureus ATCC 29213, and zones of 30 to 38 mm for S. aureus ATCC 25923. Ticarcillin-clavulanate is currently tested against other species by preparing doubling dilutions of ticarcillin with a constant 2 micrograms of clavulanate per ml. By that method, all gonococci were susceptible to low concentrations. However, the amount of clavulanic acid that is included (2 micrograms\/ml) will, by itself, inhibit many strains of N. gonorrhoeae. Consequently, the role of ticarcillin in the combination cannot be determined, and such tests are not recommended.<\/jats:p>","DOI":"10.1128\/jcm.30.8.2191-2194.1992","type":"journal-article","created":{"date-parts":[[2020,1,5]],"date-time":"2020-01-05T23:51:32Z","timestamp":1578268292000},"page":"2191-2194","update-policy":"http:\/\/dx.doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":0,"title":["Proposed interpretive criteria and quality control parameters for testing susceptibility of Neisseria gonorrhoeae to beta-lactam-clavulanate combinations"],"prefix":"10.1128","volume":"30","author":[{"given":"P C","family":"Fuchs","sequence":"first","affiliation":[{"name":"St. Vincent Hospital and Medical Center, Portland, Oregon 97225."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A L","family":"Barry","sequence":"additional","affiliation":[{"name":"St. Vincent Hospital and Medical Center, Portland, Oregon 97225."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C N","family":"Baker","sequence":"additional","affiliation":[{"name":"St. Vincent Hospital and Medical Center, Portland, Oregon 97225."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P R","family":"Murray","sequence":"additional","affiliation":[{"name":"St. Vincent Hospital and Medical Center, Portland, Oregon 97225."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J A","family":"Washington","sequence":"additional","affiliation":[{"name":"St. Vincent Hospital and Medical Center, Portland, Oregon 97225."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","container-title":["Journal of Clinical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/jcm.30.8.2191-2194.1992","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/jcm.30.8.2191-2194.1992","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T23:09:40Z","timestamp":1646435380000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/jcm.30.8.2191-2194.1992"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1992,8]]},"references-count":0,"journal-issue":{"issue":"8","published-print":{"date-parts":[[1992,8]]}},"alternative-id":["10.1128\/jcm.30.8.2191-2194.1992"],"URL":"https:\/\/doi.org\/10.1128\/jcm.30.8.2191-2194.1992","relation":{},"ISSN":["0095-1137","1098-660X"],"issn-type":[{"value":"0095-1137","type":"print"},{"value":"1098-660X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1992,8]]},"assertion":[{"value":"1992-08-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}